Entities / Company
Intuitive Surgical.
American corporation
- Reports this week
- 2
- Active events
- 1
- Connections
- 198
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Earlier this month
-
Cook Medical and Siemens introduced new iMRI systems, while Profound's technology competes with the DaVinci system.Some support3 reports
-
Intuitive Surgical received a Buy rating from Leerink partners, citing increased da Vinci placements and potential benefits from Trump-era tariffs.Some support9 reports
-
Citigroup and Baird lowered their stock targets for Intuitive Surgical on October 19, 2026.Some support1 report
-
LabCorp is involved in FDA-approved drugs. Intuitive Surgical's systems were FDA-cleared. Masimo develops noninvasive patient monitoring technologies.Some support2 reports1 development inside
-
Healthcare companies Nihon Kohden and Intuitive Surgical are competing for investment.Some support1 report
-
Medtronic entered the surgical robotics market while Eli Lilly and Novo Nordisk continued their GLP-1 drug competition.Some support1 report
-
Investors are weighing established medical giants like Intuitive Surgical and Abbott Laboratories against high-growth specialists such as Lingo.Some support1 report
-
Companies like Teradyne, UiPath, and Intuitive Surgical are offering investment opportunities in physical AI.Some support1 report
-
Medtronic is ramping up its Hugo RAS system to compete with Intuitive Surgical, while its neuroscience unit faces competitive pressure from Stryker and Globus Medical.Some support1 report1 development inside
-
Multiple wealth management firms and Barclays initiated new investment actions and coverage on Intuitive Surgical.Some support4 reports
One to three months ago
-
Barclays rated Intuitive Surgical, GE Healthcare, and Abbott Laboratories as Overweight on October 7, 2026.Some support1 report
-
Analyst targets are being lowered amid new entrants challenging market dominance for medical technology companies.Some support1 report1 development inside
-
Jim Cramer advised against Intuitive Surgical stock, citing competition from Johnson & Johnson.Some support2 reports
-
Johnson & Johnson, UnitedHealth Group, and Intuitive Surgical are noted as major players in the high-volume U.S. healthcare sector.Well supported14 reports1 development inside
-
Intuitive Surgical, Boston Scientific, and Abbott Laboratories are major players in the global healthcare device sector.Well supported3 reports1 development inside
-
Comparative financial analysis of two healthcare companies, Intuitive Surgical and IRhythm Technologies.Some support2 reports
-
Intuitive Surgical and Shopify are facing market headwinds due to investor sentiment.Some support1 report
-
RBC and Bank of America issued research reports on Intuitive Surgical.Some support3 reports
-
Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.Some support2 reports12 developments inside
-
FDA approved Medtronic's Hugo robotic system for urological procedures, marking a major competitive shift in the medical device sector.Some support1 report
-
Intuitive Surgical's operations are based in Aubonne.Some support3 reports
-
Defense Logistics Agency awarded Intuitive Surgical a contract in 2020.Some support1 report
-
JNJ secured marketing authorization from the U.S. FDA, and its Ottava platform challenges ISRG's market dominance.Some support7 reports
-
Intuitive Surgical and Thermo Fisher Scientific are operating in premium healthcare markets.Some support1 report
-
Intuitive Surgical EVP Mark Brosius sold company stock on August 19, 2026.Some support3 reports
-
Market analysts are comparing the financial health of Intuitive Surgical and Pressure BioSciences.Some support1 report
-
Intuitive Surgical's da Vinci system is being utilized for minimally invasive surgery, with AI advancements strengthening the company's market position.Well supported4 reports3 developments inside
Gone quiet
No new reports in 90+ days-
Intuitive Surgical manufactures instruments in Mexico and sources endoscopes from Germany, while HSBC downgraded its stock.Some support1 report
-
Stryker expanded its capabilities through the Mako acquisition, positioning both companies as medtech powerhouses in surgical robotics.Some support3 reports2 developments inside
-
Sector headwinds and competition increased for Moderna and Intuitive Surgical.Some support1 report
-
Johnson & Johnson faces price negotiation challenges from Medicare as MFN policy limits prices paid by government programs.Some support1 report2 developments inside
-
Surgical-robot competition from Intuitive Surgical.Some support3 reports1 development inside
-
Intuitive Surgical, Danaher Corporation, MarketBeat, and Eli Lilly and Company are featured in MarketBeat's stock screener and operate globally.Some support1 report
-
Intuitive Surgical and Johnson & Johnson are competing in the robotic surgery market, with J&J maintaining a global office in Santa Clara.Some support3 reports1 development inside
-
Domination in medical technology industry involving Intuitive Surgical, Johnson & Johnson, and Stryker.Some support1 report4 developments inside
-
Intuitive Surgical is listing its stock on the Nasdaq exchange today.Some support2 reports
-
News channels are reporting on stock activity concerning Intuitive Surgical, with information sourced via Benzinga.Some support1 report
-
U.S. procedure growth was reported, specifically noting that benign general surgery is leading the increase.Some support2 reports
-
The iShares U.S. Medical Devices ETF holds significant shares of a medical device company.Some support3 reports
-
Intuitive Surgical and Tesla are leading in advanced AI applications.Some support1 report
-
Intuitive Surgical faces pricing pressure in China and presented at a Wells Fargo conference.Well supported4 reports1 development inside
-
Amundi boosted its holdings in Intuitive Surgical, and Norges Bank bought a new stake in the company.Some support1 report1 development inside
-
Norges Bank purchased a new stake in Intuitive Surgical.Some support1 report
-
Intuitive Surgical is required to file with the SEC regarding insider trading disclosures.Some support4 reports1 development inside
-
Munich Reinsurance Co Stock Corp acquired a new stake in Intuitive Surgical shares, disclosed via SEC filings.Some support3 reports
-
Goldman Sachs analysts are arguing against market panic as they discuss downgrades following the Q1 earnings report of companies including Intuitive Surgical.Some support1 report
-
Market thesis suggests better entry points for Adobe, Intuitive Surgical, and Harley-Davidson.Some support1 report
-
Intuitive Surgical and Stryker Corporation are highlighted as medtech giants, with new deals and adoption rates driving competition in the operating room.Well supported4 reports
-
Intuitive Surgical utilizes the Da Vinci surgical robot as the Hugo system enters the market as a new competitor.Some support1 report
-
FDA approval allows market entry for devices from Dexcom and Intuitive Surgical.Some support2 reports
-
Institutional investors, including Amundi and Norges Bank, made various stake changes in Intuitive Surgical, which was reported to the SEC.Well supported3 reports
-
Deutsche Bank, Goldman Sachs, and Bank of America have recently issued research notes and adjusted price targets for Intuitive Surgical.Some support2 reports
-
Deutsche Bank reduced its price target on Intuitive Surgical, which is headquartered in Sunnyvale.Some support1 report
-
Valuation views regarding Intuitive Surgical are referenced against the city of Tokyo.Some support2 reports
-
Nvidia and Intuitive Surgical are noted as leaders in high-growth technology sectors.Some support2 reports
-
Market perception favors Intuitive Surgical over Stryker due to potential benefits from Trump-era tariffs and onshoring.Well supported3 reports1 development inside
-
Truist Financial lowered its price objective on Intuitive Surgical.Some support1 report
-
Analyst price targets affect market sentiment regarding Intuitive Surgical, which is subject to required SEC filings.Some support1 report
-
Royal Bank of Canada reduced its holdings in Intuitive Surgical by 11.0% and filed the necessary disclosures with the SEC.Some support1 report
No events began in the chosen period. Widen it, or reset.
Explainers that pass through Intuitive Surgical
Intuitive Surgical is a step on the way to someone else- Increased medical procedure adoption may boost demand for JapanIncreased medical procedure adoption may boost demand for Japanese techPossible
- Strong medical procedure growth in Korea signals robust economic activityStrong medical procedure growth in Korea signals robust economic activityPossible
- Intuitive Surgical's strong growth may increase competitive pressure on Boston ScientificIntuitive Surgical's growth may increase competitive pressure on Boston ScientificPossible
- Intuitive Surgical's strong margins may increase competitive pressure on Johnson & JohnsonIntuitive Surgical's growth may increase competitive pressure on Johnson & JohnsonPossible
Around Intuitive Surgical this week
News at the entities that move Intuitive Surgical most-
Norges Bank TransactionalNorges Bank, BNP Paribas, Morgan Stanley, and Benchmark made various investment moves regarding Datadog shares on June 15, 2026.Moves Intuitive Surgical
-
FDA StructuralThe FDA approved Miplyffa for the treatment of Niemann-Pick disease.Moves Intuitive Surgical
-
Jefferies Financial Group OperationalCitigroup reiterated a buy rating on Energy Transfer, while Jefferies Financial Group raised its rating on the company.Moves Intuitive Surgical
-
Amundi TransactionalKinder Morgan filed reports with the SEC while Amundi increased its stock holdings in the company.Moves Intuitive Surgical
-
SEC StructuralDirector Arne Wilhelmsen sold shares of Royal Caribbean Cruises Ltd. and disclosed the transaction to the SEC.Moves Intuitive Surgical
-
Johnson & Johnson OperationalJohnson & Johnson acquired Intra-Cellular Therapies and is seeking FDA approval for related drugs.Moves Intuitive Surgical
Connections
The 40 strongest of 198, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
FDA Structural
The FDA functions as the mandatory regulatory gatekeeper, granting market access and operational legitimacy to Intuitive Surgical's medical devices.
-
Da Vinci Structural
Intuitive Surgical develops, manufactures, and utilizes the Da Vinci surgical robot platform.
-
SEC Structural
Intuitive Surgical is structurally required to file mandatory reports and disclosures with the SEC regarding its financial activities.
-
Johnson & Johnson Operational
Intuitive Surgical and Johnson & Johnson are active market rivals competing for dominance in the surgical robotics and minimally invasive medical device sectors.
-
Jefferies Financial Group Operational
Jefferies Financial Group influences Intuitive Surgical's market valuation through analyst reports and coverage of major stake increases.
-
Catherine Breed Structural
Catherine Breed is currently employed by Intuitive Surgical.
-
Boston Scientific Operational
Both companies are major, leading competitors in the minimally invasive medical device market.
-
Norges Bank Transactional
Norges Bank purchased a new stake/position in Intuitive Surgical.
Show all 40 connections
-
Amundi Transactional
Amundi is actively increasing its investment holdings in Intuitive Surgical shares.
-
Securities and Exchange Commission Structural
Intuitive Surgical operates under formal reporting and oversight requirements mandated by the Securities and Exchange Commission.
-
GE Healthcare Operational
The two companies are direct competitors operating within the specialized medical device market.
-
China Operational
China's market conditions, including budgetary constraints and trade frictions, directly influence Intuitive Surgical's operational performance and competitive landscape.
-
Medtronic plc Operational
Intuitive Surgical and Medtronic plc are active competitors in the robotic-assisted surgery and medical device market.
-
ION Operational
Intuitive Surgical actively tracks the utilization and procedural throughput of the ION system.
-
Vinci Operational
The da Vinci system (A) is the core product that drives Intuitive Surgical's (B) growth and relies on a global supply chain.
-
Jim Cramer Operational
Jim Cramer provides financial commentary and stock advice regarding Intuitive Surgical's performance and outlook.
-
Stryker Corporation Operational
Both companies are major competitors in the advanced medical technology and robotic surgery markets.
-
Donald Trump Operational
A's policy shifts, including tariffs and onshoring trends, are consistently cited as factors influencing the market outlook and risk profile for B.
-
Bank of America Transactional
Bank of America issues market research reports, including price targets and downgrades, regarding Intuitive Surgical.
-
Royal Bank of Canada Operational
RBC actively provides investment research, ratings, and adjusts its holdings in Intuitive Surgical.
-
Ion Structural
Ion's platform is identified as a product of Intuitive Surgical.
-
Europe Shared context
Intuitive Surgical operates within the European market, where CE mark approval and market conditions drive system deployment and adoption.
-
HSBC Transactional
HSBC issued multiple research notes and downgraded the stock rating and target price for Intuitive Surgical.
-
Leerink partners Mentioned together
Leerink Partners provides financial analysis and ratings on Intuitive Surgical, influencing its stock valuation.
-
Adobe Operational
The competitive landscape suggests that market theses are driving potential entry points and market share battles between the two companies.
-
Penumbra Operational
Penumbra and Intuitive Surgical are active competitors within the medical instruments and healthcare equipment industry.
-
Japan Shared context
Intuitive Surgical operates within the market context of Japan, where policy and reimbursement structures dictate its growth potential.
-
Truist Financial Mentioned together
Truist Financial has issued multiple price target reductions regarding Intuitive Surgical stock.
-
Moderna Operational
Moderna and Intuitive Surgical are active competitors within the healthcare sector, facing shared market headwinds.
-
JPMorgan Chase Mentioned together
JPMorgan Chase issued a downgrade on Intuitive Surgical following their Q1 earnings report.
-
Citigroup Mentioned together
Citigroup provides financial analysis and stock target ratings for Intuitive Surgical.
-
TD Cowen Mentioned together
TD Cowen provides financial analysis, including price targets and buy ratings, for Intuitive Surgical.
-
Abbott Laboratories Operational
Both companies operate as peers and competitors within the healthcare equipment and supplies market.
-
Aubonne Shared context
Intuitive Surgical's operations are based in Aubonne.
-
Tesla Operational
Both companies are observed to be leaders in advanced AI applications, placing them in direct competition.
-
Manufacturers Life Insurance Company Transactional
Manufacturers Life Insurance Company cut its holdings in shares of Intuitive Surgical.
-
U.K. Operational
U.K. market demand conditions are shown to affect the pace of adoption for Intuitive Surgical's procedures.
-
PENTAGON Operational
Intuitive Surgical provides services or technology to the military establishment (Pentagon).
-
Teleflex Operational
Intuitive Surgical and Teleflex are direct competitors in the surgical equipment and consumables market.
-
Korea Shared context
Intuitive Surgical operates within the Korean market, which is showing accelerated utilization of robotic-assisted procedures.
History
Events by the month they beganNovember 2026
1 eventOctober 2026
8 events- Citigroup and Baird lowered their stock targets for Intuitive Surgical on October 19, 2026.
- Healthcare companies Nihon Kohden and Intuitive Surgical are competing for investment.
- Medtronic entered the surgical robotics market while Eli Lilly and Novo Nordisk continued their GLP-1 drug competition.
- Investors are weighing established medical giants like Intuitive Surgical and Abbott Laboratories against high-growth specialists such as Lingo.
- Companies like Teradyne, UiPath, and Intuitive Surgical are offering investment opportunities in physical AI.
- Multiple wealth management firms and Barclays initiated new investment actions and coverage on Intuitive Surgical.
- Barclays rated Intuitive Surgical, GE Healthcare, and Abbott Laboratories as Overweight on October 7, 2026.
- Jim Cramer advised against Intuitive Surgical stock, citing competition from Johnson & Johnson.
September 2026
7 events- Medtronic is ramping up its Hugo RAS system to compete with Intuitive Surgical, while its neuroscience unit faces competitive pressure from Stryker and Globus Medical.
- Comparative financial analysis of two healthcare companies, Intuitive Surgical and IRhythm Technologies.
- Intuitive Surgical and Shopify are facing market headwinds due to investor sentiment.
- RBC and Bank of America issued research reports on Intuitive Surgical.
- FDA approved Medtronic's Hugo robotic system for urological procedures, marking a major competitive shift in the medical device sector.
- Intuitive Surgical's operations are based in Aubonne.
- Defense Logistics Agency awarded Intuitive Surgical a contract in 2020.
Show 3 earlier months
August 2026
5 events- Intuitive Surgical and Thermo Fisher Scientific are operating in premium healthcare markets.
- Intuitive Surgical EVP Mark Brosius sold company stock on August 19, 2026.
- Market analysts are comparing the financial health of Intuitive Surgical and Pressure BioSciences.
- Intuitive Surgical manufactures instruments in Mexico and sources endoscopes from Germany, while HSBC downgraded its stock.
- Sector headwinds and competition increased for Moderna and Intuitive Surgical.
July 2026
15 events- Analyst targets are being lowered amid new entrants challenging market dominance for medical technology companies.
- Intuitive Surgical, Boston Scientific, and Abbott Laboratories are major players in the global healthcare device sector.
- JNJ secured marketing authorization from the U.S. FDA, and its Ottava platform challenges ISRG's market dominance.
- Intuitive Surgical, Danaher Corporation, MarketBeat, and Eli Lilly and Company are featured in MarketBeat's stock screener and operate globally.
- Intuitive Surgical and Johnson & Johnson are competing in the robotic surgery market, with J&J maintaining a global office in Santa Clara.
- Intuitive Surgical is listing its stock on the Nasdaq exchange today.
- News channels are reporting on stock activity concerning Intuitive Surgical, with information sourced via Benzinga.
- Intuitive Surgical and Tesla are leading in advanced AI applications.
- Norges Bank purchased a new stake in Intuitive Surgical.
- Munich Reinsurance Co Stock Corp acquired a new stake in Intuitive Surgical shares, disclosed via SEC filings.
- Goldman Sachs analysts are arguing against market panic as they discuss downgrades following the Q1 earnings report of companies including Intuitive Surgical.
- Market thesis suggests better entry points for Adobe, Intuitive Surgical, and Harley-Davidson.
- Intuitive Surgical and Stryker Corporation are highlighted as medtech giants, with new deals and adoption rates driving competition in the operating room.
- Intuitive Surgical utilizes the Da Vinci surgical robot as the Hugo system enters the market as a new competitor.
- FDA approval allows market entry for devices from Dexcom and Intuitive Surgical.
June 2026
24 events- Cook Medical and Siemens introduced new iMRI systems, while Profound's technology competes with the DaVinci system.
- Intuitive Surgical received a Buy rating from Leerink partners, citing increased da Vinci placements and potential benefits from Trump-era tariffs.
- LabCorp is involved in FDA-approved drugs. Intuitive Surgical's systems were FDA-cleared. Masimo develops noninvasive patient monitoring technologies.
- Johnson & Johnson, UnitedHealth Group, and Intuitive Surgical are noted as major players in the high-volume U.S. healthcare sector.
- Corporate activity in the medical device sector in August 2025 included M&A activity (Stryker/Inari Medical, ZimVie/Archimed), competition between Medtronic and Intuitive Surgical, and the impact of Trump administration tariffs and FDA reviews.
- Intuitive Surgical's da Vinci system is being utilized for minimally invasive surgery, with AI advancements strengthening the company's market position.
- Stryker expanded its capabilities through the Mako acquisition, positioning both companies as medtech powerhouses in surgical robotics.
- Johnson & Johnson faces price negotiation challenges from Medicare as MFN policy limits prices paid by government programs.
- Surgical-robot competition from Intuitive Surgical.
- Domination in medical technology industry involving Intuitive Surgical, Johnson & Johnson, and Stryker.
- U.S. procedure growth was reported, specifically noting that benign general surgery is leading the increase.
- The iShares U.S. Medical Devices ETF holds significant shares of a medical device company.
- Intuitive Surgical faces pricing pressure in China and presented at a Wells Fargo conference.
- Amundi boosted its holdings in Intuitive Surgical, and Norges Bank bought a new stake in the company.
- Intuitive Surgical is required to file with the SEC regarding insider trading disclosures.
- Institutional investors, including Amundi and Norges Bank, made various stake changes in Intuitive Surgical, which was reported to the SEC.
- Deutsche Bank, Goldman Sachs, and Bank of America have recently issued research notes and adjusted price targets for Intuitive Surgical.
- Deutsche Bank reduced its price target on Intuitive Surgical, which is headquartered in Sunnyvale.
- Valuation views regarding Intuitive Surgical are referenced against the city of Tokyo.
- Nvidia and Intuitive Surgical are noted as leaders in high-growth technology sectors.
- Market perception favors Intuitive Surgical over Stryker due to potential benefits from Trump-era tariffs and onshoring.
- Truist Financial lowered its price objective on Intuitive Surgical.
- Analyst price targets affect market sentiment regarding Intuitive Surgical, which is subject to required SEC filings.
- Royal Bank of Canada reduced its holdings in Intuitive Surgical by 11.0% and filed the necessary disclosures with the SEC.